81. Mirtazapine for Methamphetamine Use Disorder

In episode 81 we discuss using mirtazapine to treat methamphetamine

use disorder.

McKetin R, Shoptaw S, Saunders L, et al. Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2026;83(6):581–589. doi:10.1001/jamapsychiatry.2026.0159

We also discuss behavioral treatments added to buprenorphine,

and how the FDA is promoting flavored nicotine products.

 

JAMA Network Open: Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine

 

NBC News: Some ZYN nicotine pouches can be sold as safer than cigarettes, FDA says

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode

and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.